Substance Abuse Treatment

Substance Abuse Treatment

Global Substance Abuse Treatment Market to Reach US$20.8 Billion by 2030

The global market for Substance Abuse Treatment estimated at US$12.8 Billion in the year 2023, is expected to reach US$20.8 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2023-2030. Nicotine Addiction Treatment, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$9.4 Billion by the end of the analysis period. Growth in the Alcohol Addiction Treatment segment is estimated at 7.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.5 Billion While China is Forecast to Grow at 6.6% CAGR

The Substance Abuse Treatment market in the U.S. is estimated at US$3.5 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 6.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.5% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.

Global Substance Abuse Treatment Market - Key Trends and Drivers Summarized

Why Is Substance Abuse Treatment Gaining Importance Globally?

Substance abuse treatment is becoming increasingly essential as the prevalence of substance use disorders (SUDs) continues to rise globally. Governments and healthcare systems are under pressure to provide effective treatment solutions as drug abuse, nicotine and alcohol addiction rates grow. The treatment landscape includes a variety of interventions such as medication-assisted treatment (MAT), behavioral therapies, inpatient rehabilitation, and outpatient counseling services. With the growing societal awareness of mental health and addiction issues, coupled with government initiatives to combat opioid addiction, the need for comprehensive treatment options has become critical. Moreover, the increasing cases of prescription drug misuse and the subsequent rise in addiction rates are driving the demand for advanced treatment solutions.

How Are Technological Advancements Enhancing Substance Abuse Treatment?

The integration of technology in substance abuse treatment has transformed the way care is delivered. Telemedicine and telehealth platforms are enabling remote counseling and therapy sessions, making it easier for patients to access treatment from home. Furthermore, AI-based monitoring systems are being used to track patient progress and predict the likelihood of relapse, allowing for more personalized and proactive care plans. The adoption of mobile health apps, offering self-assessment tools, counseling support, and progress tracking, has been another important development. Additionally, digital platforms are facilitating more efficient aftercare programs, which are essential for long-term recovery, reducing relapse rates and improving patient outcomes.

Which Segments Are Leading in the Substance Abuse Treatment Market?

Treatment types include medication-assisted treatment (MAT), detoxification, counseling services, and behavioral therapy, with MAT being the most widely adopted due to its effectiveness in treating opioid addiction. Patient types can be categorized into inpatient and outpatient, with outpatient treatment services seeing significant growth due to their accessibility and cost-effectiveness. Key distribution channels include hospitals, rehabilitation centers, and mental health clinics, with rehabilitation centers holding the largest market share. Geographically, North America leads the market due to the region’s opioid crisis and strong government support for addiction treatment services, while regions like Europe and Asia-Pacific are witnessing growing awareness and investment.

What Drives Growth in the Substance Abuse Treatment Market?

The growth in the Substance Abuse Treatment market is driven by several factors, including increasing addiction rates, government support for treatment programs, and technological advancements in telehealth and mobile therapy solutions. The rising focus on mental health and awareness of substance abuse-related issues is pushing healthcare providers to expand treatment services. In addition, innovations in medication-assisted treatment (MAT) and the growing adoption of digital tools for patient monitoring and aftercare management are accelerating market growth. The opioid crisis, particularly in North America, is also a significant driver of demand for substance abuse treatment services, propelling both public and private sector investments.

Select Competitors (Total 47 Featured) -

• Alkermes PLC
• Allergan PLC
• GlaxoSmithKline PLC
• Mallinckrodt, Inc.
• Mylan NV
• Pfizer, Inc.
• Purdue Pharma LP
• Reckitt Benckiser Group plc
• Sanofi S.A.
• Teva Pharmaceuticals USA, Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.